FCS will have a large presence at the FLASCO 2024 Business Oncology Summit where statewide oncology leaders share the latest developments in oncology care.
Learn about the link between alcohol consumption and cancer risk. Find out how alcohol can increase your chances of developing various types of cancer.
FCS Study Finds Comparable Quality and Safety Outcomes in CAR T-Cell Therapy Across Accredited and Non-Accredited Centers, Highlighting Care Location as Key Driver of Patient Access and Experience
Skin Cancer PreventionLearn how to prevent skin cancer and keep your skin healthy. Discover effective strategies to reduce your risk and stay protected.
FCS Participates in Statewide Gathering to Enhance Cancer Care in Community Oncology SettingsFCS will have a large presence at the FLASCO 2024 Business Oncology Summit where statewide oncology leaders share the latest developments in oncology care.
Alcohol and Cancer RiskLearn about the link between alcohol consumption and cancer risk. Find out how alcohol can increase your chances of developing various types of cancer.
Melanoma TreatmentStay up-to-date with the latest advancements in melanoma treatment. Learn about therapies and strategies for managing skin cancer.
Adrenal Fatigue – Wellness Video SeriesAlways tired? No energy? Can’t focus? People want answers. Adrenal fatigue is an explanation that has recently grown in popularity. But is it real?
New Case Study Highlights Community Oncology Practices as Preferred Site of Service Over Hospitals and Academic CentersFCS case study evaluates the benefits of oncology care based on site of service, comparing community oncology, academic centers and hospitals.
Lucio Gordan, MD Serves on Panel of Oncology Leaders Sharing Insights with Oncology FellowsLucio N. Gordan, MD to serve as a featured panelist at the COA PrecisCa Oncology Fellows & Faculty Forum.
New Clinical Study Identifies Personalized Treatment Options for Metastatic Non-Small Cell Lung Cancer With Plasma Proteome TestingA clinical study co-authored by Ernesto Bustinza-Linares, MD has found that proteome testing leads to targeted treatment for NSCLC.